Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, indicating a newer version of the ClinicalTrials.gov study record. Several glossary terms, metadata fields, and historical labels were removed, signaling metadata cleanup and reorganization of how the study information is presented.
    Difference
    16%
    Check dated 2026-08-09T09:13:07.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now includes a Prostate cancer tag and a MedlinePlus Genetics related topics section. These additions connect the study to its disease context and provide access to related genetic information.
    Difference
    0.2%
    Check dated 2026-08-01T23:16:55.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site revision was updated from v3.6.3 to v3.6.4, indicating a new build deployment. The study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T18:34:30.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.6.2 to v3.6.3, signaling a small maintenance update to the site.
    Difference
    0.1%
    Check dated 2026-07-04T05:25:02.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added and Revision: v3.6.0 was removed, indicating a software update to the page. This change does not affect the study details, eligibility criteria, or any content about the clinical trial.
    Difference
    0.1%
    Check dated 2026-06-27T03:25:08.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate enrollment is closed, and new user-guidance sections were added to help users understand the study record and how to join. A label formatting change for Intervention/Treatment and a revision tag update were also applied.
    Difference
    0.5%
    Check dated 2026-06-12T23:36:10.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.